Face Time With The Future
By AACC Staff Posted on 27 Jun 2018 |
In their day-to-day work, clinical laboratorians often are intensely focused on the present moment: meeting turnaround time goals, calling clinicians with critical values, or troubleshooting instrument problems to make sure patients get the best care possible.
But in a broader sense, laboratory medicine always has been focused on the future. Laboratorians are known for being dissatisfied with the status quo and for continuously searching for ways to improve quality, refine measurements, or discover fresh answers to tough healthcare problems.
This dual citizenship in the present and the future explains why more than 20,000 people from all over the world gather every year at the AACC Annual Scientific Meeting & Clinical Lab Expo. Laboratorians crave new insights and meaningful connections that will nourish their natural curiosity—and professional zeal—to explore the field’s latest science and technology.
Importantly, the meeting means a lot more than just a place to process information. In an age when screen time seems ever more pervasive, a face-to-face conference offers authentic connections and an opportunity unlike any other for inspiration, refreshment, and discovery.
Here are a few ways to boost your in-person time with world-renowned experts and like-minded colleagues whom you won’t meet anywhere else.
1: POSTER WALKS
Those who have attended the AACC Annual Scientific Meeting before know that often the best way to meet colleagues and collaborators is during the poster sessions. But with nearly 1,000 posters, no one can see them all. One of the best ways to get a focused experience during the poster sessions is by attending a poster walk. Led by experts from one of AACC’s 20 scientific divisions, attendees tour posters by topic areas and participate in engaging discussions of study findings and methods. Check CLN Daily on-site for details.
2: ORAL ABSTRACT PRESENTATIONS
Each year, the Annual Meeting Organizing Committee hand-picks a series of outstanding abstracts for special oral presentations. Presenters will also be available at their posters during the poster sessions. There are six topics this year.
Monday, July 30
Global Health
Clinical Applications
Tuesday, July 31
Mass Spectrometry
Molecular Diagnostics and Genomics
Wednesday, August 1
Emerging Biomarkers and Technologies
Hot Topics in Lab Medicine
3: MEET THE EXPERTS
With attendance limited to 75 attendees, expect intensive, interactive discussions with plenary speakers Monday-Thursday of the conference. Show up early to these morning sessions and be ready with questions. Plenary speakers include:
Sunday, July 29
Brian Druker, MD: Imatinib as a Paradigm of Targeted Cancer Therapies
Monday, July 30
Kenneth Setchell, PhD: Genetic Defects in Bile Acid Synthesis—Translational Medicine from Mass Spectrometry Discovery to the Bedside
Tuesday, July 31
Denise Galloway, PhD: HPV Associated Cancers and the HPV Vaccine
Wednesday, August 1
James Collins, PhD: Nucleic Acid Detection Using CRISPR-Dx
Thursday, August 2
Timothy Amukele, MD, PhD, and Lee Schroeder, MD, PhD: Essential Diagnostics—Meeting the Needs of a Global Population
4: NEW FOR 2018: EXPLORE TOPIC TRACKS
Eight topic tracks provide paths through different areas of laboratory medicine and include both large symposia as well as more intimate brown bag sessions. Talking with fellow attendees after a symposium or during a brown bag session is a great way to gain real-world insights into the content.
Visit AACC 2018 >>
But in a broader sense, laboratory medicine always has been focused on the future. Laboratorians are known for being dissatisfied with the status quo and for continuously searching for ways to improve quality, refine measurements, or discover fresh answers to tough healthcare problems.
This dual citizenship in the present and the future explains why more than 20,000 people from all over the world gather every year at the AACC Annual Scientific Meeting & Clinical Lab Expo. Laboratorians crave new insights and meaningful connections that will nourish their natural curiosity—and professional zeal—to explore the field’s latest science and technology.
Importantly, the meeting means a lot more than just a place to process information. In an age when screen time seems ever more pervasive, a face-to-face conference offers authentic connections and an opportunity unlike any other for inspiration, refreshment, and discovery.
Here are a few ways to boost your in-person time with world-renowned experts and like-minded colleagues whom you won’t meet anywhere else.
1: POSTER WALKS
Those who have attended the AACC Annual Scientific Meeting before know that often the best way to meet colleagues and collaborators is during the poster sessions. But with nearly 1,000 posters, no one can see them all. One of the best ways to get a focused experience during the poster sessions is by attending a poster walk. Led by experts from one of AACC’s 20 scientific divisions, attendees tour posters by topic areas and participate in engaging discussions of study findings and methods. Check CLN Daily on-site for details.
2: ORAL ABSTRACT PRESENTATIONS
Each year, the Annual Meeting Organizing Committee hand-picks a series of outstanding abstracts for special oral presentations. Presenters will also be available at their posters during the poster sessions. There are six topics this year.
Monday, July 30
Global Health
Clinical Applications
Tuesday, July 31
Mass Spectrometry
Molecular Diagnostics and Genomics
Wednesday, August 1
Emerging Biomarkers and Technologies
Hot Topics in Lab Medicine
3: MEET THE EXPERTS
With attendance limited to 75 attendees, expect intensive, interactive discussions with plenary speakers Monday-Thursday of the conference. Show up early to these morning sessions and be ready with questions. Plenary speakers include:
Sunday, July 29
Brian Druker, MD: Imatinib as a Paradigm of Targeted Cancer Therapies
Monday, July 30
Kenneth Setchell, PhD: Genetic Defects in Bile Acid Synthesis—Translational Medicine from Mass Spectrometry Discovery to the Bedside
Tuesday, July 31
Denise Galloway, PhD: HPV Associated Cancers and the HPV Vaccine
Wednesday, August 1
James Collins, PhD: Nucleic Acid Detection Using CRISPR-Dx
Thursday, August 2
Timothy Amukele, MD, PhD, and Lee Schroeder, MD, PhD: Essential Diagnostics—Meeting the Needs of a Global Population
4: NEW FOR 2018: EXPLORE TOPIC TRACKS
Eight topic tracks provide paths through different areas of laboratory medicine and include both large symposia as well as more intimate brown bag sessions. Talking with fellow attendees after a symposium or during a brown bag session is a great way to gain real-world insights into the content.
• Endocrinology
• Genomics/Genetics
• Mass Spectrometry
• Pediatric/Maternal-Fetal
• Point-of-Care Testing
• Precision Medicine and Oncology
• Toxicology/Therapeutic Drug Monitoring
• Utilization and Lab Management
• Genomics/Genetics
• Mass Spectrometry
• Pediatric/Maternal-Fetal
• Point-of-Care Testing
• Precision Medicine and Oncology
• Toxicology/Therapeutic Drug Monitoring
• Utilization and Lab Management
Latest AACC 2018 News
- Mesa Biotech Showcases PCR Testing Platform at Clinical Expo
- Mindray Medical Unveils Chemiluminescence Immunoassay System at AACC 2018
- Abbott Diagnostics Displays Alinity Family of Systems
- Roche Diagnostics Highlights Latest Clinical Lab Solutions at AACC
- Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology
- Ortho Clinical Diagnostics Unveils Next-Gen Analyzer at Lab Show
- Snibe Diagnostic Presents Immunoassay Systems and Biochemistry Analyzers
- Thermo Fisher Scientific Showcases Product Portfolio at Lab Trade Show
- EKF Diagnostics Highlights Assay Kit and POC Analyzer at AACC 2018
- Randox Laboratories Showcases Advances in Biotechnology at Clinical Lab Expo
- Beckman Coulter Life Sciences Highlights Clinical Flow Cytometry Portfolio
- Beckman Coulter Features New Hematology Analyzers and Lab Automation
- Carolina Liquid Chemistries Promotes Family of Clinical Chemistry Analyzers
- Orion Diagnostica Showcases Rapid Test and Molecular Platform at Lab Show
- Saladax Biomedical Launches Game-Changing Assays at AACC 2018
- SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo
Channels
Clinical Chemistry
view channel
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more